Shrikant Havale

Title: Shrikant Havale: Innovator in Pharmaceutical Chemistry

Introduction

Shrikant Havale is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds that serve as inhibitors for specific enzymes.

Latest Patents

Havale holds a patent for "Diebenzofuran derivatives as inhibitors of PDE-4 and PDE-10." This invention relates to novel heterocyclic compounds that are useful as phosphodiesterase inhibitors, specifically targeting phosphodiesterase type 4 (PDE IV) and phosphodiesterase type 10 (PDE 10). The patent outlines processes for the preparation of these compounds, pharmaceutical compositions containing them, and their applications in treating allergic and inflammatory diseases. Additionally, these compounds are noted for their potential in inhibiting the production of Tumor Necrosis Factor (TNF-α).

Career Highlights

Havale is associated with Mylan Laboratories Limited, a prominent player in the pharmaceutical industry. His work focuses on innovative solutions that address various health challenges through the development of effective medications.

Collaborations

He has collaborated with notable colleagues such as Sreedhara Swamy Keshavapura Hosamane and Ravi Dhamjewar, contributing to the advancement of research and development in their field.

Conclusion

Shrikant Havale's contributions to pharmaceutical chemistry, particularly through his patent on PDE inhibitors, highlight his role as an innovator in the industry. His work continues to impact the development of treatments for allergic and inflammatory diseases.